Table 4 Treatment individuals received before spirometry
From: Perseverant, non-indicated treatment of obese patients for obstructive lung disease
Normal (62) | Restriction (35) | COPD (36) | Asthma (11) | |
|---|---|---|---|---|
Inhaled Beta 2 -agonists | 40.3% (25) | 54.3% (19) | 69.4% (25) | 72.7% (8) |
Inhaled corticosteroids | 16.1% (10) | 28.6% (10) | 38.9% (14) | 63.6% (7) |
Inhaled Anticholinergic | 14.5% (9) | 14.3% (5) | 33.3% (12) | 9.1% (1) |
Oral corticosteroids | 8.1% (5) | 14.3% (5) | 13.9% (5) | 9.1% (1) |
Leukotriene antagonists | 1.6% (1) | 0 | 5.6% (2) | 18.2% (2) |